IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 521 - 540 of 1271 stories.
October 23, 2012
Mylan buys API plant in India Active pharmaceutical ingredients (API), intermediates and formulations manufacturer SMS Pharmaceuticals (Hyderabad, India) informed the Bombay Stock...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-23-October_47147.html
October 23, 2012
Active pharmaceutical ingredients (API), intermediates, and formulations manufacturer SMS Pharmaceuticals (Hyderabad, India) informed the Bombay Stock Exchange (Mumbai) that its board...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mylan-buys-API-plant-in-India_47146.html
October 23, 2012
Sinochem (Beijing) says it signed a memorandum of strategic cooperation, at Shanghai on 21 August, with PTT Global Chemical (Bangkok), Thailand's largest integrated petrochemical and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sinochem-and-PTT-Global-Chemical-sign-cooperation-deal-for-fine-chemicals-business_47140.html
October 19, 2012
Albany Molecular Research Inc. (AMRI; Albany) says it has entered into a mult-year active pharmaceutical ingredient (API) supply agreement for an undisclosed product with Shire US...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AMRI-extends-API-supply-deal-with-Shire_47078.html
October 17, 2012
Albemarle’s third-quarter net income fell 14% year-on-year, to $99.3 million, on sales down 8.5% to $661.2 million. Earnings totaled $1.10/share, beating analysts’...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-net-income-falls-14-percent-on-pricing-and-volume-declines_47047.html
October 16, 2012
Frutarom Industries (Haifa, Israel) is building a new R&D center and manufacturing plant for flavors and fragrances at Haifa, Israel. The investment is about $30 million, the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Frutarom-expands-production-capacity-builds-R-and-D-center-in-Israel_47017.html
October 16, 2012
Avantor Performance Materials (Center Valley, PA) has signed a collaboration agreement with Rubicon Research (Mumbai) to develop, manufacture, and market products for the functional...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Avantor-signs-development-agreement-with-Rubicon-Research-for-pharma-excipients_47016.html
October 16, 2012
Dr. Reddy’s Laboratories (Hyderabad, India), the second largest API company in the world in terms of sales, after Teva, says that it will open a new large-scale active...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Dr-Reddys-builds-large-scale-API-facility-in-India_46975.html
October 16, 2012
Saltigo shuts US site Saltigo (Langenfeld, Germany), a Lanxess subsidiary, says it has discontinued production at the company’s Redmond, WA, site and that it has abandoned a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-16-October_47001.html
October 15, 2012
DSM Sinochem Pharmaceuticals (DSP; Singapore), the former DSM Anti-Infectives business, says that it is planning to build production capacity for manufacturing the active...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-DSM-Sinochem-Pharmaceuticals-to-build-Atorvastatin-facility-in-India_46973.html
October 15, 2012
Aesica Pharmaceuticals (Newcastle, UK), a provider of active pharmaceutical ingredients (APIs), formulations, and custom synthesis, says that it plans to triple annual revenues from...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Aesica-to-triple-API-sales-in-three-years-to-acquire-assets-in-North-America-and-India-next-year_46883.html
October 12, 2012
Saltigo (Langenfeld, Germany), a Lanxess subsidiary, says it has discontinued production at the company’s Redmond, WA, site and that it has abandoned a previously announced...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Saltigo-shuts-US-site-abandons-plans-to-build-potent-API-capacity_46888.html
October 10, 2012
Novasep (Pompey, France) announced at the CPhI trade fair at Madrid that it will invest €30 million ($39 million) to build the world’s largest chromatography plant for the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novasep-to-build-worlds-largest-chromatography-plant-in-France_46851.html
October 10, 2012
Codexis (Redwood City, CA), a company that develops industrial enzymes to enable the production of pharmaceuticals, biofuels, and biobased chemicals, says that it continues to...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Codexis-focuses-on-innovator-companies_46819.html
October 9, 2012
Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) says that it expects the drug product business to be the growth driver for Hovione post 2015, and that...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Drug-product-manufacturing-business-to-drive-growth-for-Hovione_46843.html
October 9, 2012
The US FDA did a good job of implementing the Generic Drug User Fee Act (GDUFA), but has disappointed as far as the falsified medicines directive (FMD) of the European Union (EU) is...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EFCG-at-CPhI-FDA-did-well-to-implement-GDUFA-but-disappoints-with-FMD-_46844.html
October 9, 2012
Tessenderlo Group said today that it intends to sell its pharmaceutical ingredients activities Farchemia and Calaire Chimie to International Chemical Investors Group (ICIG; Frankfurt)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Tessenderlo-Group-sells-pharma-ingredients-business-to-International-Chemical-Investors_46813.html
October 4, 2012
Sigma-Aldrich Fine Chemicals (SAFC; St. Louis, MO), a life science company, plans to expand its Scotland operations with the development of a new powder manufacturing facility at its...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sigma-Aldrich-Begins-Construction-of-Powder-Manufacturing-Facility-at-U-K-Site_46581.html
October 3, 2012
Pharmaceutical company Daiichi Sankyo (Tokyo) says it has decided to reorganize three of its supply chain subsidiaries in Japan – Daiichi Sankyo Propharma (DSPP; Tokyo), Daiichi...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Daiichi-Sankyo-to-restructure-pharma-ingredient-subsidiaries_46639.html
October 3, 2012
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI) says it has expanded the capacity of its active pharmaceutical ingredient (API) manufacturing plant in Wisconsin. CHP is a contract...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cedarburg-Hauser-Expands-API-Production-Capacity_46548.html
Pages: « Previous  18 19 20 21 22 23 24 25 26 [27] 28 29 30 31 32 33 34 35 36 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa